Xapavir LT Tablet 30s

About Xapavir LT Tablet 30s:

Xapavir LT Tablet 30s is a combination medication in tablet form primarily used for the treatment of HIV infection. It helps in controlling the virus and improving the immune system's function.

Composition of Xapavir LT Tablet 30s:

• Dolutegravir (50mg): An integrase inhibitor that prevents the virus from multiplying by blocking the integrase enzyme.
• Lamivudine (300mg): A nucleoside reverse transcriptase inhibitor (NRTI) that stops the virus from replicating by inhibiting the reverse transcriptase enzyme.
• Tenofovir disoproxil fumarate (300mg): Another NRTI that works similarly to Lamivudine, further preventing viral replication.

Xapavir LT Tablet 30s Therapeutic Class:

The therapeutic class of Xapavir LT Tablet 30s is antiretroviral therapy. It is specifically designed to manage and treat HIV infection by reducing the viral load in the body.

Xapavir LT Tablet 30s Uses and Indications:

• Treatment of HIV-1 infection in adults and adolescents.
• Helps in reducing the viral load in the body.
• Improves the immune system function.
• Prevents the progression of HIV to AIDS.

How Xapavir LT Tablet 30s Works (Mechanism of Action):

Xapavir LT Tablet 30s works by combining three active ingredients that target different stages of the HIV life cycle. Dolutegravir inhibits the integrase enzyme, preventing the integration of viral DNA into the host cell's DNA. Lamivudine and Tenofovir disoproxil fumarate inhibit the reverse transcriptase enzyme, blocking the conversion of viral RNA into DNA, thus preventing replication.

• Dolutegravir blocks the integrase enzyme.
• Lamivudine inhibits reverse transcriptase.
• Tenofovir disoproxil fumarate also inhibits reverse transcriptase.

Xapavir LT Tablet 30s Storage Conditions:

Store Xapavir LT Tablet 30s at room temperature, between 20°C to 25°C (68°F to 77°F). Keep it in a dry place, away from direct sunlight and moisture.

Manufacturer Name of Xapavir LT Tablet 30s:

Xapavir LT Tablet 30s is manufactured by Natco Pharma Ltd, a reputable pharmaceutical company known for producing high-quality medications. They are committed to ensuring the safety and efficacy of their products.

WHO-GMP Certification Status of Xapavir LT Tablet 30s:

Natco Pharma Ltd, the manufacturer of Xapavir LT Tablet 30s, is WHO-GMP certified, ensuring that the product meets international quality standards for pharmaceutical manufacturing.

Alternative Brands for Xapavir LT Tablet 30s:

• Triumeq
• Odimune
• Symfi
• Delstrigo

Recent Regulatory or Official Updates on Xapavir LT Tablet 30s:

Recent regulatory updates from CDSCO and WHO have highlighted the importance of combination therapies like Xapavir LT Tablet 30s in the management of HIV, emphasizing their role in improving patient outcomes.

User Feedback Summary for Xapavir LT Tablet 30s (User Opinions):

• Users report improved viral load control.
• Many experience fewer side effects compared to other treatments.
• Positive feedback on the convenience of a single tablet regimen.
• Some users note improved quality of life.

Disclaimer: Individual experiences may vary. Follow medical advice.

Conclusion:

Xapavir LT Tablet 30s, containing Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate, is an antiretroviral therapy used to treat HIV. Manufactured by Natco Pharma Ltd, it is WHO-GMP certified, ensuring quality and efficacy. Always consult healthcare professionals for personalized medical advice.